Fluidigm Corporation (FLDM) 10.40 $FLDM Fluidigm to

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Fluidigm Corporation (FLDM) 10.40 $FLDM

Fluidigm to Announce Q2 2016 Financial Results and Host Conference Call for Investors
GlobeNewswire - Thu Jul 28, 3:01PM CDT
Fluidigm Corporation (NASDAQ:FLDM) today announced it will report second quarter 2016 financial results on Thursday, August 4, 2016, after the financial markets close.
FLDM: 10.40 (+0.13)

Fluidigm Announces New Customer Inspiration Center in Canada for Mass Cytometry
GlobeNewswire - Thu Jun 09, 8:00AM CDT
Fluidigm Corporation (NASDAQ:FLDM) today announced the opening of a new customer inspiration center in Markham, Ontario, Canada. Providing researchers with firsthand experience on the Helios(TM) system, the latest mass cytometry instrument using CyTOF technology, the customer inspiration center will be open to investigators around the world seeking to incorporate mass cytometry in their own research laboratories.
FLDM: 10.40 (+0.13)

Fluidigm Introduces Single-Cell TCR Sequencing on the C1 System at Immunology 2016(TM)
GlobeNewswire - Mon May 16, 8:00AM CDT
Fluidigm Corporation (NASDAQ:FLDM) today announced the introduction of Single-Cell TCR Sequencing, a new immunology application on the C1(TM) system that enables in-depth profiling of T cells at single-cell resolution. Uncovering the unique T cell receptor (TCR) alpha and beta chains from each cell in conjunction with the corresponding gene expression signature, Single-Cell TCR Sequencing provides researchers with a novel approach to interrogate the functional response of each T cell. This information can provide new insights into the biological mechanisms that govern the body's response to infectious disease, the regulation of autoimmune or allergic reactions and the development of effective immunotherapies.
FLDM: 10.40 (+0.13)

Fluidigm reports 1Q loss
Automated Insights - Thu May 05, 8:53AM CDT
SOUTH SAN FRANCISCO, Calif. (AP) _ Fluidigm Corp. (FLDM) on Thursday reported a loss of $19.9 million in its first quarter.
FLDM: 10.40 (+0.13)

Fluidigm Announces First Quarter Financial Results
GlobeNewswire - Thu May 05, 6:25AM CDT
Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the first quarter ended March 31, 2016.
FLDM: 10.40 (+0.13)

Fluidigm Announces New Integrated Fluidic Circuits for Single-Cell Genomics on the C1 System
GlobeNewswire - Tue Apr 12, 7:44AM CDT
Fluidigm Corporation (NASDAQ:FLDM) today announced new integrated fluidic circuits (IFCs) that will increase the number of single cells that can be isolated and analyzed on the C1(TM) system. Bringing together the trusted Fluidigm C1 single-cell isolation system with the benefits of a growing suite of optimized microfluidic circuits, researchers can confidently expand their single-cell studies while taking advantage of well-established, industry-proven workflows.
FLDM: 10.40 (+0.13)

Clontech Laboratories, Inc. Releases the SMART-Seq v4 Ultra Low Input RNA Kit for the Fluidigm C1 System
PR Newswire - Wed Apr 06, 12:00PM CDT
Clontech Laboratories, Inc., a wholly owned subsidiary of Takara Bio Inc., and Fluidigm Corporation today announced the recent launch of Clontech's SMART-Seq v4 Ultra Low Input RNA Kit for the Fluidigm C1 System. This kit, which is available for 4 and 10 IFCs (integrated fluidic circuits), allows high-quality cDNA synthesis starting from 96 single cells that have been isolated and processed with the Fluidigm C1 System, using a script available in the Fluidigm Script Hub.
FLDM: 10.40 (+0.13)

Fluidigm Q4 Loss Narrower than Expected, Revenues Fall Y/Y
Zacks Equity Research - Zacks Investment Research - Wed Feb 10, 11:20AM CST
Fluidigm reported adjusted loss of 38 cents per share in fourth-quarter 2015, narrower than the Zacks Consensus Estimate of 48 cents.
ABMD: 119.46 (-0.04), FLDM: 10.40 (+0.13), LMNX: 21.60 (-0.26), CRY: 14.19 (-0.13)

Fluidigm Announces Fourth Quarter and Full Year 2015 Financial Results
GlobeNewswire - Thu Feb 04, 3:00PM CST
Fluidigm Corporation (NASDAQ:FLDM) today announced its financial results for the fourth quarter and full year ended December 31, 2015.
FLDM: 10.40 (+0.13)

Fluidigm to Announce Q4-Full Year 2015 Financial Results and Host Conference Call for Investors
GlobeNewswire - Thu Jan 28, 4:30PM CST
Fluidigm Corporation (NASDAQ:FLDM) will report its fourth quarter and full year 2015 financial results on February 4, 2016, after close of market.
FLDM: 10.40 (+0.13)

Global Liquid Biopsy Markets Market Size, Strategies and Forecasts 2016 to 2020
M2 - Tue Jan 26, 4:48AM CST
Research and Markets (http://www.researchandmarkets.com/research/v2x28v/liquid_biopsy) has announced the addition of the "Liquid Biopsy Markets Global Market Size, Strategies and Forecasts 2016 to 2020" report to their offering. The Diagnostic, Monitoring and Screening Test opportunities are explored. A revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. GRAIL, a new company with impressive backing, has announced a single blood test to detect all cancers. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has outstanding growth potential. The impact on the health care industry is enormous. The report forecasts the market size out to 2020. In addition, the report looks at potential market sizes by country, by cancer and by the three different opportunities: detection, management and screening. Use independent research that makes you the expert. Get our research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. We wrote this report and we are ready, by phone or email, to help you use it. Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size. The report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate and Other Cancers. What is the size of the huge screening opportunity? Key Topics Covered: 1. Introduction and Market Definition 2. Market Overview 3. Market Trends 4. Liquid Biopsy Recent Developments 5. Country Market Sizes - North America 6. Country Markets - Europe 7. Country Markets - Asia Pacific 8. Country Markets - Latin America, Africa & The Middle East 9. Global Market Summary 10. Potential Market Opportunity Sizes Companies Mentioned - ASCO - AdnaGen (now Qiagen) - Agena Bioscience - Angle plc - ApoCell - AstraZeneca - Baylor - Bio-Rad Laboratories - BioFluidica - Biocept - Biodesix - Boreal Genomics - Broad Institute - CRUK Manchester Institute - Chronix Biomedical - Clearbridge BioMedics - Cynvenio - CytoTrack - Cytolumina Technologies Corp - Diagnologix LLC - Epic Sciences - Exosome - Fluidigm Corp - Fluxion Biosciences - GRAIL - Genomic Health - Guardant Health - HTG Molecular Diagnostics - HansaBiomed - Horizon Discovery - Illumina - Inivata - Janssen Diagnostics - Merck Serono - Molecular MD For more information visit http://www.researchandmarkets.com/research/v2...uid_biopsy
FLDM: 10.40 (+0.13), MRK: 58.50 (-0.16), HTGM: 2.41 (-0.02), GHDX: 29.82 (-0.52)

Fluidigm's Q4 Preliminary Results Fail to Woo Investors
Zacks Equity Research - Zacks Investment Research - Tue Jan 19, 12:40PM CST
Market is not really upbeat about Fluidigm Corporation's (FLDM) preliminary results for the fourth quarter of 2015.
FLDM: 10.40 (+0.13), BIO: 147.50 (-1.15), ILMN: 166.69 (-3.96), EXAC: 26.94 (-0.26)

Accuray Expands EIMEA Footprint with New Installations
Zacks Equity Research - Zacks Investment Research - Fri Jan 15, 12:10PM CST
Accuray Inc. (ARAY) recently installed CyberKnife M6 system in Qatar and Latvia.
ABMD: 119.46 (-0.04), FLDM: 10.40 (+0.13), EXAC: 26.94 (-0.26), ARAY: 5.47 (+0.02)

Masimo's Patient SafetyNet & Radius-7 Demand on the Rise
Zacks Equity Research - Zacks Investment Research - Fri Jan 15, 12:00PM CST
Masimo Corp (MASI) recently announced that Watauga Medical Center in Boone, North Carolina, has decided to install Patient SafetyNet with Radius-7.
ABMD: 119.46 (-0.04), MASI: 52.76 (-0.17), FLDM: 10.40 (+0.13), EXAC: 26.94 (-0.26)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Elite Robots Expands Global Reach with Mobile Manipulators

Updated Category News Views 105

Robots Hitting the Road? Picture this: robots that aren't just bolted to a factory floor but roam the production lines like tireless workers on wheels. That's what Elite Robots is betting on with their shiny new ELITEMISSION mobile manipulators. Not Just Any Old Robot These bad boys combine a robotic arm with an autonomous mobile platform. Think of an octopus getting off...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 228

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
Lululemon Faces Class Action over Alleged Missteps

Updated Category News Views 13

Trouble Brewing for Lululemon Y'ever get that gut feeling when something doesn't smell right? Well, Lululemon Athletica (NASDAQ: LULU) investors are probably feeling that now. A class action's kicking up dust over what some are saying was a downright bumpy ride. The brainiacs at Robbins LLP urge those who've lost bucks riding the LULU train to step forward ahead of the...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 147

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Dr. Kumar Joins Florida Cancer Specialists Team

Updated Category News Views 29

Welcoming a New Oncology Specialist to Bradenton What does a small but mighty addition mean for cancer care in Bradenton, Florida? Well, it feels like a big win for the locals. Dr. Vinod Kumar is the latest name to join the ranks of the Florida Cancer Specialists & Research Institute (FCS) at the Bradenton Cancer Center. With years under his belt in medical oncology and...

Continue Reading
Tips for a Dementia-Friendly Thanksgiving Gathering

Updated Category News Views 28

Thanksgiving's supposed to bring families round the table, right? But toss a few knuckleheads together, add a pinch of dementia, and suddenly it's like throwing dice at a craps table. The American Speech-Language-Hearing Association (ASHA) reckons they've got tricks up their sleeve to keep the holiday from unraveling. The Thanksgiving Reality Check The hustle, bustle, and...

Continue Reading
ICEYE Launches Gen5 SAR Satellite for Unrivaled Clarity

Updated Category News Views 60

Well, if you've been sleeping under a rock and missed the news, ICEYE just dropped another bombshell in the satellite biz. Gen5 is the name of the game, and it's claiming the spotlight for its razor-sharp imaging prowess. Now, we're talking about a satellite that supposedly snaps pictures with a resolution as fine as 11 cm. That's like spotting a flea on a dog's back from...

Continue Reading
Carolina Pines Tackles Rural Healthcare Myths on TV

Updated Category News Views 47

Rural Healthcare Battles the Big City Myth Picture this: you're in a tiny town where everyone knows your dog's name, but some think you've got to head to the city for top-notch medical care. That's where Carolina Pines Regional Medical Center steps in. They’ve snagged a spot on 'All Access with Andy Garcia', shining a light on how investments in tech and talent keep...

Continue Reading
2GenPen's Patent Push: Transforming Credit Analysis

Updated Category News Views 7

Changing the Game in Credit Analysis When you hear about a company snagging a patent, it's usually a big whoop-de-do; but 2GenPen's latest achievement is making some serious waves. This isn't some 'pat-yourself-on-the-back' sort of news – it's got teeth in the world of finance. These folks just locked down their second U.S. patent, number 12,784,096, and it's all about...

Continue Reading
Flagship's £100M London Move to Ignite AI Ventures

Updated Category News Views 131

London Calling: Flagship's New Venture Flagship Pioneering, the brain behind bustling biotech ventures like Moderna, is planting its flag in London. They're launching Flagship Origination Lab, U.K., their first real gig outside good ol' Cambridge, Massachusetts. They're diving in headfirst, sprinkling a whopping £100 million to brew up AI-native platform companies. And...

Continue Reading

Top 5 Most Recently Viewed Articles

Empowering Innovation: Schneider Electric's Climate Tech Event

Updated Category News Views 170

Exploring the Excitement of the Climate Tech in the City Event The Climate Tech in the City event embodies the spirit of innovation, uniting key players in the climate technology sector. Leading organizations like Schneider Electric are at the forefront, showcasing groundbreaking advancements and sustainable practices. This year's gathering promises a vibrant day filled...

Continue Reading
Ouster Transforms Chattanooga into a Smart Traffic Hub

Updated Category News Views 404

Ouster's Groundbreaking Initiative in Smart Traffic Management In a significant development for urban traffic management, Ouster, Inc. (NASDAQ: OUST), recognized for its state-of-the-art lidar sensors, has launched a transformative project in Chattanooga. This venture stands out as the largest lidar-enabled traffic system in the United States, boasting a remarkable...

Continue Reading
Bicara Therapeutics Business Highlights and Q1 2025 Financial Review

Updated Category News Views 520

Bicara Therapeutics Announces Key Developments and Q1 2025 Financial Results Latest data from ongoing clinical trials to be showcased at upcoming conferences. Strong financial position enables sustained development through 2029. Bicara Therapeutics Inc. (Nasdaq: BCAX), a pioneering clinical-stage biopharmaceutical firm, focuses on delivering groundbreaking bifunctional...

Continue Reading
IO Biotech Gears Up for December Conferences: Insights and Highlights

Updated Category News Views 148

IO Biotech Prepares for Key Investor Conferences IO Biotech, a trailblazer in developing groundbreaking immune-modulatory cancer vaccines, is set to join two prominent investor events this December. The company, listed under NASDAQ: IOBT, is known for its innovative approach in the biopharmaceutical industry, particularly in creating off-the-shelf therapeutic cancer...

Continue Reading
Cardinal Energy Secures $40 Million Through Latest Debenture Offering

Updated Category News Views 267

Cardinal Energy Ltd. Announces a Major Offering Cardinal Energy Ltd. is excited to inform investors about its latest initiative aimed at raising funds through a significant offering. The company has entered into an agreement with a selected group of underwriters who will help facilitate the sale of $40 million in senior subordinated unsecured debentures. This strategic...

Continue Reading